The Latest Analyst Ratings for IDEAYA Biosciences
Portfolio Pulse from Benzinga Insights
IDEAYA Biosciences (NASDAQ:IDYA) has received positive analyst ratings in the last quarter, with 1 bullish and 4 somewhat bullish ratings. The average 12-month price target for the company has increased by 8.62% to $34.4, with a high of $40.00 and a low of $32.00.
August 11, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
IDEAYA Biosciences has received positive analyst ratings, which could potentially boost investor confidence and the stock price in the short term.
Analyst ratings often influence investor sentiment and can impact a company's stock price. In this case, IDEAYA Biosciences has received predominantly positive ratings, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100